RESUMO
Occurrence of hyperglycemia upon infection is associated with worse clinical outcome in COVID-19 patients. However, it is still unknown whether SARS-CoV-2 directly triggers hyperglycemia. Herein, we interrogated whether and how SARS-CoV-2 causes hyperglycemia by infecting hepatocytes and increasing glucose production. We performed a retrospective cohort study including patients that were admitted at a hospital with suspicion of COVID-19. Clinical and laboratory data were collected from the chart records and daily blood glucose values were analyzed to test the hypothesis on whether COVID-19 was independently associated with hyperglycemia. Blood glucose was collected from a subgroup of nondiabetic patients to assess pancreatic hormones. Postmortem liver biopsies were collected to assess the presence of SARS-CoV-2 and its transporters in hepatocytes. In human hepatocytes, we studied the mechanistic bases of SARS-CoV-2 entrance and its gluconeogenic effect. SARS-CoV-2 infection was independently associated with hyperglycemia, regardless of diabetic history and beta cell function. We detected replicating viruses in human hepatocytes from postmortem liver biopsies and in primary hepatocytes. We found that SARS-CoV-2 variants infected human hepatocytes in vitro with different susceptibility. SARS-CoV-2 infection in hepatocytes yields the release of new infectious viral particles, though not causing cell damage. We showed that infected hepatocytes increase glucose production and this is associated with induction of PEPCK activity. Furthermore, our results demonstrate that SARS-CoV-2 entry in hepatocytes occurs partially through ACE2- and GRP78-dependent mechanisms. SARS-CoV-2 infects and replicates in hepatocytes and exerts a PEPCK-dependent gluconeogenic effect in these cells that potentially is a key cause of hyperglycemia in infected patients.
Assuntos
COVID-19 , Hiperglicemia , Humanos , COVID-19/complicações , SARS-CoV-2 , Gluconeogênese , Glicemia , Estudos Retrospectivos , Hepatócitos , Hiperglicemia/complicações , GlucoseRESUMO
Perivascular adipose tissue (PVAT) negatively regulates vascular muscle contraction. However, in the context of obesity, the PVAT releases vasoconstrictor substances that detrimentally affect vascular function. A pivotal player in this scenario is the peptide endothelin-1 (ET-1), which induces oxidative stress and disrupts vascular function. This study postulates that obesity augments ET-1 production in the PVAT, decreases the function of the nuclear factor erythroid 2-related factor-2 (Nrf2) transcription factor, further increasing reactive oxygen species (ROS) generation, culminating in PVAT dysfunction. Male C57BL/6 mice were fed either a standard or a high-fat diet for 16 weeks. Mice were also treated with saline or a daily dose of 100 mg.kg-1 of the ETA and ETB receptor antagonist Bosentan, for 7 days. Vascular function was evaluated in thoracic aortic rings, with and without PVAT. Mechanistic studies utilized PVAT from all groups and cultured WT-1 mouse brown adipocytes. PVAT from obese mice exhibited increased ET-1 production, increased ECE1 and ETA gene expression, loss of the anticontractile effect, as well as increased ROS production, decreased Nrf2 activity, and downregulated expression of Nrf2-targeted antioxidant genes. PVAT of obese mice also exhibited increased expression of Tyr216-phosphorylated-GSK3ß and KEAP1, but not BACH1 - negative Nrf2 regulators. Bosentan treatment reversed all these effects. Similarly, ET-1 increased ROS generation and decreased Nrf2 activity in brown adipocytes, events mitigated by BQ123 (ETA receptor antagonist). These findings place ET-1 as a major contributor to PVAT dysfunction in obesity and highlight that pharmacological control of ET-1 effects restores PVAT's cardiovascular protective role.
RESUMO
BACKGROUND: The release of neutrophil extracellular traps (NETs) is associated with inflammation, coagulopathy, and organ damage found in severe cases of COVID-19. However, the molecular mechanisms underlying the release of NETs in COVID-19 remain unclear. OBJECTIVES: We aim to investigate the role of the Gasdermin-D (GSDMD) pathway on NETs release and the development of organ damage during COVID-19. METHODS: We performed a single-cell transcriptome analysis in public data of bronchoalveolar lavage. Then, we enrolled 63 hospitalized patients with moderate and severe COVID-19. We analyze in blood and lung tissue samples the expression of GSDMD, presence of NETs, and signaling pathways upstreaming. Furthermore, we analyzed the treatment with disulfiram in a mouse model of SARS-CoV-2 infection. RESULTS: We found that the SARS-CoV-2 virus directly activates the pore-forming protein GSDMD that triggers NET production and organ damage in COVID-19. Single-cell transcriptome analysis revealed that the expression of GSDMD and inflammasome-related genes were increased in COVID-19 patients. High expression of active GSDMD associated with NETs structures was found in the lung tissue of COVID-19 patients. Furthermore, we showed that activation of GSDMD in neutrophils requires active caspase1/4 and live SARS-CoV-2, which infects neutrophils. In a mouse model of SARS-CoV-2 infection, the treatment with disulfiram inhibited NETs release and reduced organ damage. CONCLUSION: These results demonstrated that GSDMD-dependent NETosis plays a critical role in COVID-19 immunopathology and suggests GSDMD as a novel potential target for improving the COVID-19 therapeutic strategy.
Assuntos
Tratamento Farmacológico da COVID-19 , Armadilhas Extracelulares , Animais , Dissulfiram/metabolismo , Armadilhas Extracelulares/metabolismo , Camundongos , Neutrófilos/metabolismo , SARS-CoV-2RESUMO
PURPOSE: Obesity results in decreased lung function and increased inflammation. Moderate aerobic exercise (AE) reduced lung inflammation and remodeling in a variety of respiratory disease models. Therefore, this study investigated whether AE can attenuate a diet-induced obesity respiratory phenotype; including airway hyper-responsiveness (AHR), remodeling and inflammation. METHODS: Sixty C57Bl/6 male mice were distributed into four groups: control lean (CL), exercise lean (EL), obese (O) and obese exercise (OE) groups (2 sets of 7 and 8 mice per group; nâ¯=â¯15). A classical model of diet-induced obesity (DIO) over 12â¯weeks was used. AE was performed 60â¯min/day, 5â¯days/week for 5â¯weeks. Airway hyperresponsiveness (AHR), lung inflammation and remodeling, adipokines and cytokines in bronchoalveolar lavage (BAL) was determined. RESULTS: A high fat diet over 18â¯weeks significantly increased body weight (pâ¯<â¯.0001). Five weeks of AE significantly reduced both AHR and pulmonary inflammation. AHR in obese mice that exercised was reduced at the basal level (pâ¯<â¯.05), vehicle (PBS) (pâ¯<â¯.05), 6.25 MCh mg/mL (pâ¯<â¯.05), 12.5 MCh mg/mL (pâ¯<â¯.01), 25 MCh mg/mL (pâ¯<â¯.01) and 50 MCh mg/mL (pâ¯<â¯.05). Collagen (pâ¯<â¯.001) and elastic (pâ¯<â¯.001) fiber deposition in airway wall and also smooth muscle thickness (pâ¯<â¯.001) were reduced. The number of neutrophils (pâ¯<â¯.001), macrophages (pâ¯<â¯.001) and lymphocytes (pâ¯<â¯.01) were reduced in the peribronchial space as well as in the BAL: lymphocytes (pâ¯<â¯.01), macrophages (pâ¯<â¯.01), neutrophils (pâ¯<â¯.001). AE reduced obesity markers leptin (pâ¯<â¯.001), IGF-1 (pâ¯<â¯.01) and VEGF (pâ¯<â¯.001), while increased adiponectin (pâ¯<â¯.01) in BAL. AE also reduced pro-inflammatory cytokines in the BAL: IL-1ß (pâ¯<â¯.001), IL-12p40 (pâ¯<â¯.001), IL-13 (pâ¯<â¯.01), IL-17 (pâ¯<â¯.001, IL-23 (pâ¯<â¯.05) and TNF-alpha (pâ¯<â¯.05), and increased anti-inflammatory cytokine IL-10 (pâ¯<â¯.05). CONCLUSIONS: Aerobic exercise reduces high fat diet-induced obese lung phenotype (AHR, pulmonary remodeling and inflammation), involving anti-inflammatory cytokine IL-10 and adiponectin.
Assuntos
Obesidade/complicações , Condicionamento Físico Animal , Hipersensibilidade Respiratória/etiologia , Hipersensibilidade Respiratória/prevenção & controle , Animais , Biomarcadores/metabolismo , Colágeno/metabolismo , Dieta Hiperlipídica , Elastina/metabolismo , Inflamação/patologia , Masculino , Camundongos Endogâmicos C57BL , FenótipoRESUMO
Impairment of nitric oxide (NO)-mediated cavernosal relaxations in middle age contributes to erectile dysfunction. However, little information is available about the alterations of sympathetic neurotransmission and contraction in erectile tissue at middle age. This study aimed to evaluate the alterations of the contractile machinery associated with tyrosine hydroxylase (TH) in rat corpus cavernosum (RCC) at middle age, focusing on the role of superoxide anion. Male Wistar young (3.5-mo) and middle-aged (10-mo) rats were used. Electrical-field stimulation (EFS)- and phenylephrine-induced contractions were obtained in RCC strips. Levels of reactive-oxygen species (ROS) and TH mRNA expression, as well as protein expressions for α1/ß1-subunits of soluble guanylyl cyclase (sGC), in RCC were evaluated. The neurogenic contractile responses elicited by EFS (4-32 Hz) were greater in RCC from the middle-aged group that was accompanied by elevated TH mRNA expression (P < 0.01). Phenylephrine-induced contractions were also greater in the middle-aged group. A 62% increase in ROS generation in RCC from middle-aged rats was observed. The mRNA expression for the α1A-adrenoceptor remained unchanged among groups. Protein levels of α1/ß1-sGC subunits were decreased in RCC from the middle-aged compared with young group. The NADPH oxidase inhibitor apocynin (85 mg·rat(-1)·day(-1), 4 wk) fully restored the enhanced ROS production, TH mRNA expressions, and α1/ß1-subunit sGC expression, indicating that excess of superoxide anion plays a major role in the sympathetic hyperactivity and hypercontractility in erectile tissue at middle age. Reduction of oxidative stress by dietary antioxidants may be an interesting approach to treat erectile dysfunction in aging population.
Assuntos
Envelhecimento/metabolismo , Guanilato Ciclase/metabolismo , Impotência Vasculogênica/fisiopatologia , Contração Muscular , Músculo Liso/inervação , Estresse Oxidativo , Ereção Peniana , Pênis/inervação , Receptores Citoplasmáticos e Nucleares/metabolismo , Sistema Nervoso Simpático/fisiopatologia , Agonistas de Receptores Adrenérgicos alfa 1/farmacologia , Fatores Etários , Animais , Relação Dose-Resposta a Droga , Regulação para Baixo , Estimulação Elétrica , Inibidores Enzimáticos/farmacologia , Impotência Vasculogênica/enzimologia , Masculino , Contração Muscular/efeitos dos fármacos , Músculo Liso/enzimologia , NADPH Oxidases/antagonistas & inibidores , NADPH Oxidases/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Ereção Peniana/efeitos dos fármacos , Pênis/irrigação sanguínea , RNA Mensageiro/metabolismo , Ratos Wistar , Receptores Adrenérgicos alfa 1/metabolismo , Guanilil Ciclase Solúvel , Superóxidos , Sistema Nervoso Simpático/efeitos dos fármacos , Tirosina 3-Mono-Oxigenase/genética , Tirosina 3-Mono-Oxigenase/metabolismoRESUMO
The COVID-19 pandemic was initiated by the rapid spread of a SARS-CoV-2 strain. Though mainly classified as a respiratory disease, SARS-CoV-2 infects multiple tissues throughout the human body, leading to a wide range of symptoms in patients. To better understand how SARS-CoV-2 affects the proteome from cells with different ontologies, this work generated an infectome atlas of 9 cell models, including cells from brain, blood, digestive system, and adipocyte tissue. Our data shows that SARS-CoV-2 infection mainly trigger dysregulations on proteins related to cellular structure and energy metabolism. Despite these pivotal processes, heterogeneity of infection was also observed, highlighting many proteins and pathways uniquely dysregulated in one cell type or ontological group. These data have been made searchable online via a tool that will permit future submissions of proteomic data ( https://reisdeoliveira.shinyapps.io/Infectome_App/ ) to enrich and expand this knowledgebase.
Assuntos
COVID-19 , SARS-CoV-2 , Humanos , Proteômica , PandemiasRESUMO
Obesity induces chronic inflammation resulting in insulin resistance and metabolic disorders. Cold exposure can improve insulin sensitivity in humans and rodents, but the mechanisms have not been fully elucidated. Here, we find that cold resolves obesity-induced inflammation and insulin resistance and improves glucose tolerance in diet-induced obese mice. The beneficial effects of cold exposure on improving obesity-induced inflammation and insulin resistance depend on brown adipose tissue (BAT) and liver. Using targeted liquid chromatography with tandem mass spectrometry, we discovered that cold and ß3-adrenergic stimulation promote BAT to produce maresin 2 (MaR2), a member of the specialized pro-resolving mediators of bioactive lipids that play a role in the resolution of inflammation. Notably, MaR2 reduces inflammation in obesity in part by targeting macrophages in the liver. Thus, BAT-derived MaR2 could contribute to the beneficial effects of BAT activation in resolving obesity-induced inflammation and may inform therapeutic approaches to combat obesity and its complications.
Assuntos
Tecido Adiposo Marrom , Resistência à Insulina , Tecido Adiposo Marrom/metabolismo , Animais , Ácidos Docosa-Hexaenoicos , Inflamação/metabolismo , Camundongos , Obesidade/metabolismoRESUMO
Clinical and experimental data indicate that severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection is associated with significant changes in the composition and function of intestinal microbiota. However, the relevance of these effects for SARS-CoV-2 pathophysiology is unknown. In this study, we analyzed the impact of microbiota depletion after antibiotic treatment on the clinical and immunological responses of K18-hACE2 mice to SARS-CoV-2 infection. Mice were treated with a combination of antibiotics (kanamycin, gentamicin, metronidazole, vancomycin, and colistin, Abx) for 3 days, and 24 h later, they were infected with SARS-CoV-2 B lineage. Here, we show that more than 80% of mice succumbed to infection by day 11 post-infection. Treatment with Abx had no impact on mortality. However, Abx-treated mice presented better clinical symptoms, with similar weight loss between infected-treated and non-treated groups. We observed no differences in lung and colon histopathological scores or lung, colon, heart, brain and kidney viral load between groups on day 5 of infection. Despite some minor differences in the expression of antiviral and inflammatory markers in the lungs and colon, no robust change was observed in Abx-treated mice. Together, these findings indicate that microbiota depletion has no impact on SARS-CoV-2 infection in mice.
Assuntos
Tratamento Farmacológico da COVID-19 , Microbiota , Enzima de Conversão de Angiotensina 2 , Animais , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Modelos Animais de Doenças , Melfalan , Camundongos , Camundongos Transgênicos , Peptidil Dipeptidase A/metabolismo , SARS-CoV-2 , gama-GlobulinasRESUMO
Visceral adiposity is a risk factor for severe COVID-19, and a link between adipose tissue infection and disease progression has been proposed. Here we demonstrate that SARS-CoV-2 infects human adipose tissue and undergoes productive infection in fat cells. However, susceptibility to infection and the cellular response depends on the anatomical origin of the cells and the viral lineage. Visceral fat cells express more ACE2 and are more susceptible to SARS-CoV-2 infection than their subcutaneous counterparts. SARS-CoV-2 infection leads to inhibition of lipolysis in subcutaneous fat cells, while in visceral fat cells, it results in higher expression of pro-inflammatory cytokines. Viral load and cellular response are attenuated when visceral fat cells are infected with the SARS-CoV-2 gamma variant. A similar degree of cell death occurs 4-days after SARS-CoV-2 infection, regardless of the cell origin or viral lineage. Hence, SARS-CoV-2 infects human fat cells, replicating and altering cell function and viability in a depot- and viral lineage-dependent fashion.
Assuntos
COVID-19 , SARS-CoV-2 , Tecido Adiposo , Enzima de Conversão de Angiotensina 2 , Citocinas , HumanosRESUMO
OBJECTIVE: To investigate the role of physical activity in functional and molecular bladder alterations in an obese and insulin-resistant murine model. METHODS: Wistar rats were randomized into 1. physical activity and standard diet; 2. physical activity and high-fat diet; 3. no physical activity and standard diet; and 4. no physical activity and high-fat diet. Groups 1 and 2 were subjected to a 10-week swimming protocol. Urodynamic study (UDS) was performed, and the expression of genes in the bladder tissue related to the insulin pathway (IRS1/IRS2/PI3K/AKT/eNOS) was assessed using quantitative real-time polymerase chain reaction. RESULTS: Groups 1 and 2 presented lower body weight gains than groups 3 (213.89 ± 13.77 vs 261.63 ± 34.20 grams (g), p = 0.04) and 4 (209.84 ± 27.40 vs 257.57 ± 32.95 g, p = 0.04), respectively. Group 4 had higher insulin level (6.05 ± 1.79 vs 4.14 ± 1.14 ng/ml, p = 0.038) and higher homeostasis model assessment of insulin resistance (HOMA-IR) index (1.95 ± 0.73 vs 1.09 ± 0.37, p = 0.006) than group 1. On UDS, group 4 had greater number of micturition (13.6 ± 4.21 vs 6.0 ± 1.82, p = 0.04), higher postvoid pressure (8.06 ± 2.24 vs 5.08 ± 1.23, p = 0.04), lower capacity (0.29 ± 0.18 vs 0.91 ± 0.41 ml, p = 0.008), and lower bladder compliance (0.027 ± 0.014 vs 0.091 ± 0.034 ml/mmHg, p = 0.016) versus group 1. High-fat diet was related to an underexpression throughout insulin signaling pathway, and physical activity was related to an overexpression of the pathway. CONCLUSIONS: The insulin signaling pathway may be involved in the pathogenesis of bladder dysfunction related to a high-fat diet. Physical activity may help to prevent bladder disfunction induced by a high-fat diet through the insulin pathway.
Assuntos
Resistência à Insulina , Obesidade/fisiopatologia , Condicionamento Físico Animal/métodos , Bexiga Urinária/fisiopatologia , Animais , Masculino , Óxido Nítrico/metabolismo , Ratos , Ratos Wistar , Bexiga Urinária/metabolismo , UrodinâmicaRESUMO
Distinct oxygenases and their oxylipin products have been shown to participate in thermogenesis by mediating physiological adaptations required to sustain body temperature. Since the role of the lipoxygenase (LOX) family in cold adaptation remains elusive, we aimed to investigate whether, and how, LOX activity is required for cold adaptation and to identify LOX-derived lipid mediators that could serve as putative cold mimetics with therapeutic potential to combat diabetes. By utilizing mass-spectrometry-based lipidomics in mice and humans, we demonstrated that cold and ß3-adrenergic stimulation could promote the biosynthesis and release of 12-LOX metabolites from brown adipose tissue (BAT). Moreover, 12-LOX ablation in mouse brown adipocytes impaired glucose uptake and metabolism, resulting in blunted adaptation to the cold in vivo. The cold-induced 12-LOX product 12-HEPE was found to be a batokine that improves glucose metabolism by promoting glucose uptake into adipocytes and skeletal muscle through activation of an insulin-like intracellular signaling pathway.
Assuntos
Tecido Adiposo Marrom/metabolismo , Araquidonato 12-Lipoxigenase/fisiologia , Resposta ao Choque Frio/fisiologia , Metabolismo Energético/fisiologia , Obesidade/metabolismo , Adipócitos Marrons/metabolismo , Adipócitos Marrons/patologia , Animais , Linhagem Celular , Feminino , Glucose/metabolismo , Humanos , Masculino , Camundongos , Termogênese/fisiologiaRESUMO
Impairment of nitric oxide (NO) - cyclic GMP signaling pathway is likely to contribute to human begnin prostate hyperplasia (BPH). In the present study we have used a model of chronic NO synthesis inhibition to evaluate the functional alterations of prostate smooth muscle (PSM) machinery, and involvement of Rho-kinase pathway. Wistar rats were treated with the NO inhibitor N(ω)-nitro-l-arginine methyl ester (L-NAME, 20mg/kg/day; 4 weeks), after which contractile responses to phenylephrine (α1-adrenoceptor agonist; 1nM to 100µM), carbachol (muscarinic agonist; 1nM to 1mM) and α,ß-methylene ATP (P2X receptor agonist; 1-10µM), as well as to electrical-field stimulation (EFS; 1-32Hz) were evaluated. PSM relaxations to isoproterenol (non-selective ß-adrenoceptor agonist, 0.1nM to 10µM) and sodium nitroprusside (NO donor, 1nM to 10mM) were also evaluated. The ratio prostate weight/body weight was 22% greater (P<0.05) in L-NAME compared with control group. The PSM contractions to phenylephrine, carbachol and α,ß-methylene ATP were higher in L-NAME (Emax: 3.85±0.25, 3.52±0.35 and 2.03±0.2mN, respectively) compared with control group (Emax: 3.08±0.17, 2.37±0.18 and 1.57±0.18mN, respectively). The PSM contractions induced by EFS were also significantly greater in L-NAME group. Prior incubation with the Rho-kinase inhibitor Y27632 (1µM) fully reversed the enhanced contractions to phenylephrine and carbachol. Isoproterenol-induced PSM relaxations were 34% lower in L-NAME group, which was associated with reduced levels of cAMP in prostate tissue. The relaxations to sodium nitroprusside remained unaltered in L-NAME group. In summary, chronic NO deficiency leads to increased Rho-kinase-mediated PSM contractile responses accompanied by impairment of ß-adrenergic-cAMP-signaling pathway.
Assuntos
AMP Cíclico/metabolismo , Óxido Nítrico/deficiência , Próstata/metabolismo , Quinases Associadas a rho/metabolismo , Trifosfato de Adenosina/análogos & derivados , Amidas/farmacologia , Animais , Carbacol/farmacologia , GMP Cíclico/metabolismo , Relação Dose-Resposta a Droga , Estimulação Elétrica , Isoproterenol/farmacologia , Masculino , Contração Muscular/efeitos dos fármacos , Músculo Liso/efeitos dos fármacos , NG-Nitroarginina Metil Éster/farmacologia , Óxido Nítrico/metabolismo , Nitroprussiato/farmacologia , Fenilefrina , Próstata/efeitos dos fármacos , Piridinas/farmacologia , Ratos , Transdução de Sinais/efeitos dos fármacos , Quinases Associadas a rho/antagonistas & inibidoresRESUMO
BACKGROUND: Urological complications associated with sickle cell disease (SCD), include nocturia, enuresis, urinary infections and urinary incontinence. However, scientific evidence to ascertain the underlying cause of the lower urinary tract symptoms in SCD is lacking. OBJECTIVE: Thus, the aim of this study was to evaluate urinary function, in vivo and ex vivo, in the Berkeley SCD murine model (SS). METHODS: Urine output was measured in metabolic cage for both wild type and SS mice (25-30 g). Bladder strips and urethra rings were dissected free and mounted in organ baths. In isolated detrusor smooth muscle (DSM), relaxant response to mirabegron and isoproterenol (1nM-10µM) and contractile response to (carbachol (CCh; 1 nM-100µM), KCl (1 mM-300mM), CaCl2 (1µM-100mM), α,ß-methylene ATP (1, 3 and 10 µM) and electrical field stimulation (EFS; 1-32 Hz) were measured. Phenylephrine (Phe; 10nM-100µM) was used to evaluate the contraction mechanism in the urethra rings. Cystometry and histomorphometry were also performed in the urinary bladder. RESULTS: SS mice present a reduced urine output and incapacity to produce typical bladder contractions and bladder emptying (ex vivo), compared to control animals. In DSM, relaxation in response to a selective ß3-adrenergic agonist (mirabegron) and to a non-selective ß-adrenergic (isoproterenol) agonist were lower in SS mice. Additionally, carbachol, α, ß-methylene ATP, KCl, extracellular Ca2+ and electrical-field stimulation promoted smaller bladder contractions in SS group. Urethra contraction induced by phenylephrine was markedly reduced in SS mice. Histological analyses of SS mice bladder revealed severe structural abnormalities, such as reductions in detrusor thickness and bladder volume, and cell infiltration. CONCLUSIONS: Taken together, our data demonstrate, for the first time, that SS mice display features of urinary bladder dysfunction, leading to impairment in urinary continence, which may have an important role in the pathogenesis of the enuresis and infections observed the SCD patients.
Assuntos
Anemia Falciforme/fisiopatologia , Modelos Animais de Doenças , Bexiga Urinária/fisiopatologia , Acetanilidas/farmacologia , Trifosfato de Adenosina/análogos & derivados , Trifosfato de Adenosina/farmacologia , Anemia Falciforme/patologia , Animais , Atropina/farmacologia , Cloreto de Cálcio , Carbacol/farmacologia , Diurese , Estimulação Elétrica , Hemoglobina Falciforme/genética , Humanos , Isoproterenol/farmacologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Contração Muscular/efeitos dos fármacos , Músculo Liso/efeitos dos fármacos , Músculo Liso/fisiopatologia , Fenilefrina/farmacologia , Cloreto de Potássio/farmacologia , Tiazóis/farmacologia , Uretra/efeitos dos fármacos , Uretra/fisiopatologia , Bexiga Urinária/efeitos dos fármacos , Bexiga Urinária/patologiaRESUMO
Agonists such as icilin and menthol can activate the cool temperature-sensitive ion channel TRPM8. However, biological responses to menthol may occur independently of TRPM8 activation. In the rodent urinary bladder, menthol facilitates the micturition reflex but inhibits muscarinic contractions of the detrusor smooth muscle. The site(s) of TRPM8 expression in the bladder are controversial. In this study we investigated the regulation of bladder contractility in vitro by menthol. Bladder strips from wild type and TRPM8 knockout male mice (25-30 g) were dissected free and mounted in organ baths. Isometric contractions to carbachol (1 nM-30 µM), CaCl2 (1 µM to 100 mM) and electrical field stimulation (EFS; 8, 16, 32 Hz) were measured. Strips from both groups contracted similarly in response to both carbachol and EFS. Menthol (300 µM) or nifedipine (1 µM) inhibited carbachol and EFS-induced contractions in both wild type and TRPM8 knockout bladder strips. Incubation with the sodium channel blocker tetrodotoxin (1 µM), replacement of extracellular sodium with the impermeant cation N-Methyl-D-Glucamine, incubation with a cocktail of potassium channel inhibitors (100 nM charybdotoxin, 1 µM apamin, 10 µM glibenclamide and 1 µM tetraethylammonium) or removal of the urothelium did not affect the inhibitory actions of menthol. Contraction to CaCl2 was markedly inhibited by either menthol or nifedipine. In cultured bladder smooth muscle cells, menthol or nifedipine abrogated the carbachol or KCl-induced increases in [Ca2+]i. Intravesical administration of menthol increased voiding frequency while decreasing peak voiding pressure. We conclude that menthol inhibits muscarinic bladder contractions through blockade of L-type calcium channels, independently of TRPM8 activation.
Assuntos
Mentol/administração & dosagem , Contração Muscular/efeitos dos fármacos , Músculo Liso/fisiologia , Canais de Cátion TRPM/metabolismo , Bexiga Urinária/fisiologia , Animais , Bloqueadores dos Canais de Cálcio/farmacologia , Cloreto de Cálcio/metabolismo , Carbacol/farmacologia , Células Cultivadas , Estimulação Elétrica/métodos , Técnicas In Vitro , Masculino , Mentol/farmacologia , Camundongos , Camundongos Knockout , Nifedipino/farmacologia , Canais de Cátion TRPM/genética , Tetrodotoxina/farmacologiaRESUMO
A positive relationship between obesity and asthma has been well documented. The AMP-activated protein kinase (AMPK) activator metformin reverses obesity-associated insulin resistance (IR) and inhibits different types of inflammatory responses. This study aimed to evaluate the effects of metformin on the exacerbation of allergic eosinophilic inflammation in obese mice. Male C57BL6/J mice were fed for 10 weeks with high-fat diet (HFD) to induce obesity. The cell infiltration and inflammatory markers in bronchoalveolar lavage (BAL) fluid and lung tissue were evaluated at 48 h after ovalbumin (OVA) challenge. HFD obese mice displayed peripheral IR that was fully reversed by metformin (300 mg/kg/day, two weeks). OVA-challenge resulted in higher influx of total cell and eosinophils in lung tissue of obese mice compared with lean group. As opposed, the cell number in BAL fluid of obese mice was reduced compared with lean group. Metformin significantly reduced the tissue eosinophil infiltration and prevented the reduction of cell counts in BAL fluid. In obese mice, greater levels of eotaxin, TNF-α and NOx, together with increased iNOS protein expression were observed, all of which were normalized by metformin. In addition, metformin nearly abrogated the binding of NF-κB subunit p65 to the iNOS promoter gene in lung tissue of obese mice. Lower levels of phosphorylated AMPK and its downstream target acetyl CoA carboxylase (ACC) were found in lung tissue of obese mice, which were restored by metformin. In separate experiments, the selective iNOS inhibitor aminoguanidine (20 mg/kg, 3 weeks) and the anti-TNF-α mAb (2 mg/kg) significantly attenuated the aggravation of eosinophilic inflammation in obese mice. In conclusion, metformin inhibits the TNF-α-induced inflammatory signaling and NF-κB-mediated iNOS expression in lung tissue of obese mice. Metformin may be a good pharmacological strategy to control the asthma exacerbation in obese individuals.
Assuntos
Asma/complicações , Inflamação/prevenção & controle , Metformina/farmacologia , Obesidade/complicações , Proteínas Quinases Ativadas por AMP/metabolismo , Animais , Western Blotting , Líquido da Lavagem Broncoalveolar/citologia , Dieta Hiperlipídica/efeitos adversos , Inibidores Enzimáticos/farmacologia , Eosinófilos/efeitos dos fármacos , Eosinófilos/metabolismo , Eosinófilos/patologia , Guanidinas/farmacologia , Hipoglicemiantes/farmacologia , Inflamação/etiologia , Resistência à Insulina , Pulmão/efeitos dos fármacos , Pulmão/metabolismo , Pulmão/patologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Óxido Nítrico/metabolismo , Óxido Nítrico Sintase Tipo II/antagonistas & inibidores , Óxido Nítrico Sintase Tipo II/genética , Óxido Nítrico Sintase Tipo II/metabolismo , Obesidade/etiologia , Obesidade/metabolismo , Ovalbumina/farmacologia , Regiões Promotoras Genéticas/genética , Ligação Proteica , Fator de Transcrição RelA/metabolismo , Fator de Necrose Tumoral alfa/metabolismoRESUMO
Obesidade/síndrome metabólica são fatores de risco para o desenvolvimento dos sintomas do trato urinário inferior (LUTS), incluindo hiperatividade de bexiga. Em nosso estudo visamos investigar a relação entre resistência à insulina e hiperatividade de bexiga em modelo de obesidade induzida por dieta hiperlipídica (10 semanas) em camundongos C57BL6/J. Curvas concentração-resposta a diferentes agentes contráteis e à insulina foram realizadas em bexigas isoladas de camundongos e humanos. Estudo cistométrico foi conduzido em camundongos anestesiados. Expressão protéica de PKC, canais de Ca2+ do tipo L, eNOS (Ser1177) e AKT (Ser473) fosforiladas, bem como de marcadores da resposta a proteínas mal dobradas (UPR), TRIB3, CHOP e ATF4, foi determinada por western blot. Camundongos obesos exibiram aumento do peso corpóreo, gordura epididimal, glicemia de jejum e resistência à insulina. As respostas contráteis aos diferentes agentes foram maiores nos animais obesos, o que foi normalizado pela pré-incubação com o bloqueador dos canais de Ca2+ do tipo L, amlodipino. Animais do grupo obeso apresentaram hiperatividade de bexiga, como demonstrado por estudo cistométrico. As curvas concentração-resposta ao agonista muscarínico, carbacol, foram dependentes da ativação da PKC. A resposta contrátil ao ativador da PKC, PDBu, foi abolida pela incubação com amlodipino. O tratamento com metformina melhorou a sensibilidade à insulina assim como normalizou a hipercontratilidade in vitro, a hiperatividade de bexiga e os níveis de PKC e pAKT em camundongos obesos. A insulina (1-100 nM) produziu relaxamento concentração-dependente em bexigas de camundongos e humanos, o que foi reduzido pela remoção da camada urotelial ou inibição da via de sinalização da PI3K/AKT/eNOS. Em condições fisiológicas, o estímulo com insulina resultou em um aumento de aproximadamente 3 vezes nos níveis de GMPc; porém, o relaxamento e os níveis de GMPc foram menores em bexigas de animais obesos...
Obesity/metabolic syndrome are common risk factors for lower urinary tract symptoms, including overactive bladder. This study aimed to investigate whether insulin resistance affects bladder function in a model of obesity induced by high-fat diet (10 weeks) in C57BL6/J mice. Concentration-response curves to contractile agents and insulin were performed in human and mouse bladders. Cystometric study was performed in terminally anaesthetized mice. Western blot was performed in bladders to detect PKC, Cav1.2, phosphorylated eNOS (Ser1177) and AKT (Ser473), as well as the unfolded protein response (UPR) markers TRIB3, CHOP and ATF4. Obese mice exhibited higher body weight, epididymal fat mass, fasting glucose and insulin resistance. All the contractile agents produced greater bladder contractions in obese mice, which were fully reversed by the Cav1.2 blocker amlodipine. Cystometry evidenced overactive bladder in obese group that were also prevented by amlodipine. Carbachol induced contractions was dependent on the PKC activation, and PKC expression was increased in obese mice. Metformin treatment improved the insulin sensitivity, normalized the in vitro bladder hypercontractility, cystometric dysfunction and restored PKC and pAKT expression in the obese bladders. Insulin (1-100 nM) produced concentration-dependent mouse and human bladder relaxations that were markedly reduced by mucosal removal or inhibition of the PI3K/AKT/eNOS pathway. In mouse bladders, insulin produced a 3.0-fold increase in cGMP levels (P<0.05), that was prevented by PI3K/AKT/eNOS pathway inhibition. PI3K inhibition abolished insulin-induced phosphorylation of AKT and eNOS in bladder mucosa. Obese mice showed greater voiding frequency and non-voiding contractions, indicating overactive bladder...